Biomimetic nanoparticles for inflammation targeting-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Biomimetic nanoparticles for inflammation targeting

Published:2018-01 Issue:1 Volume:8 Page:23-33
ISSN:2211-3835
Container-title:Acta Pharmaceutica Sinica B
language:en
Short-container-title:Acta Pharmaceutica Sinica B

Author:

Jin Kai,Luo Zimiao,Zhang Bo,Pang Zhiqing

Funder

National Natural Science Foundation of China

National Basic Research Program of China

Publisher

Elsevier BV

Subject

General Pharmacology, Toxicology and Pharmaceutics

Reference101 articles.

1. Reparative inflammation takes charge of tissue regeneration;Karin;Nature,2016

2. Immunity, inflammation, and cancer;Grivennikov;Cell,2010

3. Inflammation and atherosclerosis: a review of the role of interleukin-6 in the development of atherosclerosis and the potential for targeted drug therapy;Hartman;Cardiol Rev,2014

4. Vascular targeting of nanocarriers: perplexing aspects of the seemingly straightforward paradigm;Howard;ACS Nano,2014

5. Targeted nanocarriers for imaging and therapy of vascular inflammation;Chacko;Curr Opin Colloid Interface Sci,2011

Cited by 269 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sclareol exerts an anti-inflammatory effect, possibly through COXs inhibition pathway: In vivo and in silico studies;Pharmaceutical Science Advances;2024-12

2. Nanoparticles in drinking water: Assessing health risks and regulatory challenges;Science of The Total Environment;2024-11

3. Advances in synthetic biology-based drug delivery systems for disease treatment;Chinese Chemical Letters;2024-11

4. Circulating tumor cells: from new biological insights to clinical practice;Signal Transduction and Targeted Therapy;2024-09-02

5. Exploring the regulatory role of tsRNAs in the TNF signaling pathway: Implications for cancer and non-cancer diseases;Progress in Biophysics and Molecular Biology;2024-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3